Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Melanoma × Exercise Test × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 3 Prostatic Neoplasms 2 Breast Neoplasms 2 Urinary Bladder Neoplasms 1 Radiation Pneumonitis 1 Radiation Fibrosis Syndrome 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pelvic Neoplasms 1 Pancreatic Neoplasms 1 Multiple Myeloma 1 Melanoma 1 Malignant Solid Neoplasm 1 Malignant Primary Pelvic Neoplasm 1 Lymphoma, Non-Hodgkin 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hodgkin Disease 1 Hematopoietic and Lymphatic System Neoplasm 1 Heart Defects, Congenital 1 Colorectal Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Merkel Cell 1 Anatomic Stage I Breast Cancer American Joint Committee on Cancer (AJCC) v8 1

Interventions

pembrolizumab 50 Nivolumab 49 Ipilimumab 27 Cyclophosphamide 15 Specimen Handling 10 Radiosurgery 10 Magnetic Resonance Spectroscopy 10 fludarabine 9 Opdualag 9 Biopsy 8 relatlimab 7 binimetinib 7 aldesleukin 7 Interleukin-2 7 Blood Specimen Collection 7 encorafenib 5 cemiplimab 5 Paclitaxel 5 Immunotherapy 5 Bevacizumab 5 toripalimab 4 atezolizumab 4 Temozolomide 4 CTLA-4 Antigen 4 trametinib 3 spartalizumab 3 lifileucel 3 fludarabine phosphate 3 dabrafenib 3 Surgical Procedures, Operative 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06008977 2025-06-04

EX-BOOST

AdventHealth Translational Research Institute

Phase NA Recruiting

Melanoma, Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡